FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2048692401> ?p ?o ?g. }

• W2048692401 endingPage "851" @default.
• W2048692401 startingPage "845" @default.
• W2048692401 abstract "Purpose To evaluate the efficacy of recombinant tissue plasminogen activator (rtPA) injected by pulse-spray in lysing subclavian and jugular venous thrombi. Materials and Methods Twelve patients with symptomatic, venogram-confirmed, occlusive thrombi of the subclavian-axillary or jugular veins were treated with one or two daily 15-minute injections of rtPA delivered directly into the clots with pulse-spray catheters. Twenty-four hours after each treatment, repeated veno-grams were obtained to assess venous patency. Successful thrombolysis was defined as antegrade flow through the previously occluded segments with minimal collateral venous flow. Continued patency was assessed with repeated venograms obtained after 1 and 2 months of oral anticoagulation. Results The 15-minute rtPA injections successfully lysed thrombi in eight of the 12 patients. Hypofibrinogenemia developed in only one patient. The technique had a high success rate with thrombi less than 2 weeks old (seven of eight) regardless of the length of the clot, but had limited success with thrombi more than 2 weeks old (one of four). Continued patency over a 2-month interval was documented in four of the eight patients whose thrombi were successfully lysed. However, patency could be maintained in only one of the four patients who retained a venous access device in the treated vein. Conclusion Pulse spray rtPA is an effective, safe, and practical alternative to continuous infusions of thrombolytic agents to treat upper extremity venous thrombi. To evaluate the efficacy of recombinant tissue plasminogen activator (rtPA) injected by pulse-spray in lysing subclavian and jugular venous thrombi. Twelve patients with symptomatic, venogram-confirmed, occlusive thrombi of the subclavian-axillary or jugular veins were treated with one or two daily 15-minute injections of rtPA delivered directly into the clots with pulse-spray catheters. Twenty-four hours after each treatment, repeated veno-grams were obtained to assess venous patency. Successful thrombolysis was defined as antegrade flow through the previously occluded segments with minimal collateral venous flow. Continued patency was assessed with repeated venograms obtained after 1 and 2 months of oral anticoagulation. The 15-minute rtPA injections successfully lysed thrombi in eight of the 12 patients. Hypofibrinogenemia developed in only one patient. The technique had a high success rate with thrombi less than 2 weeks old (seven of eight) regardless of the length of the clot, but had limited success with thrombi more than 2 weeks old (one of four). Continued patency over a 2-month interval was documented in four of the eight patients whose thrombi were successfully lysed. However, patency could be maintained in only one of the four patients who retained a venous access device in the treated vein. Pulse spray rtPA is an effective, safe, and practical alternative to continuous infusions of thrombolytic agents to treat upper extremity venous thrombi." @default.
• W2048692401 created "2016-06-24" @default.
• W2048692401 creator A5009923339 @default.
• W2048692401 creator A5015886522 @default.
• W2048692401 creator A5022743944 @default.
• W2048692401 creator A5050092822 @default.
• W2048692401 date "1996-11-01" @default.
• W2048692401 modified "2023-09-27" @default.
• W2048692401 title "Pulse-Spray Treatment of Subclavian and Jugular Venous Thrombi with Recombinant Tissue Plasminogen Activator" @default.
• W2048692401 cites W1994196027 @default.
• W2048692401 cites W2014776178 @default.
• W2048692401 cites W2021762400 @default.
• W2048692401 cites W2030680498 @default.
• W2048692401 cites W204612893 @default.
• W2048692401 cites W2047786411 @default.
• W2048692401 cites W2049490014 @default.
• W2048692401 cites W2050800630 @default.
• W2048692401 cites W2067816014 @default.
• W2048692401 cites W2089976423 @default.
• W2048692401 cites W2107355614 @default.
• W2048692401 cites W2138849164 @default.
• W2048692401 cites W2153008754 @default.
• W2048692401 cites W2176619818 @default.
• W2048692401 cites W2338618131 @default.
• W2048692401 cites W93029923 @default.
• W2048692401 doi "https://doi.org/10.1016/s1051-0443(96)70858-8" @default.
• W2048692401 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8951751" @default.
• W2048692401 hasPublicationYear "1996" @default.
• W2048692401 type Work @default.
• W2048692401 sameAs 2048692401 @default.
• W2048692401 citedByCount "43" @default.
• W2048692401 countsByYear W20486924012012 @default.
• W2048692401 countsByYear W20486924012013 @default.
• W2048692401 countsByYear W20486924012014 @default.
• W2048692401 countsByYear W20486924012015 @default.
• W2048692401 countsByYear W20486924012016 @default.
• W2048692401 countsByYear W20486924012017 @default.
• W2048692401 countsByYear W20486924012020 @default.
• W2048692401 countsByYear W20486924012022 @default.
• W2048692401 crossrefType "journal-article" @default.
• W2048692401 hasAuthorship W2048692401A5009923339 @default.
• W2048692401 hasAuthorship W2048692401A5015886522 @default.
• W2048692401 hasAuthorship W2048692401A5022743944 @default.
• W2048692401 hasAuthorship W2048692401A5050092822 @default.
• W2048692401 hasConcept C126322002 @default.
• W2048692401 hasConcept C141071460 @default.
• W2048692401 hasConcept C164705383 @default.
• W2048692401 hasConcept C2775836813 @default.
• W2048692401 hasConcept C2776572282 @default.
• W2048692401 hasConcept C2777956836 @default.
• W2048692401 hasConcept C2779581417 @default.
• W2048692401 hasConcept C2780931571 @default.
• W2048692401 hasConcept C2781267111 @default.
• W2048692401 hasConcept C2781362458 @default.
• W2048692401 hasConcept C2911092318 @default.
• W2048692401 hasConcept C3020199598 @default.
• W2048692401 hasConcept C500558357 @default.
• W2048692401 hasConcept C541997718 @default.
• W2048692401 hasConcept C71924100 @default.
• W2048692401 hasConceptScore W2048692401C126322002 @default.
• W2048692401 hasConceptScore W2048692401C141071460 @default.
• W2048692401 hasConceptScore W2048692401C164705383 @default.
• W2048692401 hasConceptScore W2048692401C2775836813 @default.
• W2048692401 hasConceptScore W2048692401C2776572282 @default.
• W2048692401 hasConceptScore W2048692401C2777956836 @default.
• W2048692401 hasConceptScore W2048692401C2779581417 @default.
• W2048692401 hasConceptScore W2048692401C2780931571 @default.
• W2048692401 hasConceptScore W2048692401C2781267111 @default.
• W2048692401 hasConceptScore W2048692401C2781362458 @default.
• W2048692401 hasConceptScore W2048692401C2911092318 @default.
• W2048692401 hasConceptScore W2048692401C3020199598 @default.
• W2048692401 hasConceptScore W2048692401C500558357 @default.
• W2048692401 hasConceptScore W2048692401C541997718 @default.
• W2048692401 hasConceptScore W2048692401C71924100 @default.
• W2048692401 hasIssue "6" @default.
• W2048692401 hasLocation W20486924011 @default.
• W2048692401 hasLocation W20486924012 @default.
• W2048692401 hasOpenAccess W2048692401 @default.
• W2048692401 hasPrimaryLocation W20486924011 @default.
• W2048692401 hasRelatedWork W105927076 @default.
• W2048692401 hasRelatedWork W1980165169 @default.
• W2048692401 hasRelatedWork W1992396105 @default.
• W2048692401 hasRelatedWork W2058414660 @default.
• W2048692401 hasRelatedWork W2058940296 @default.
• W2048692401 hasRelatedWork W2141559324 @default.
• W2048692401 hasRelatedWork W2172070502 @default.
• W2048692401 hasRelatedWork W2412351740 @default.
• W2048692401 hasRelatedWork W2888708448 @default.
• W2048692401 hasRelatedWork W4236156329 @default.
• W2048692401 hasVolume "7" @default.
• W2048692401 isParatext "false" @default.
• W2048692401 isRetracted "false" @default.
• W2048692401 magId "2048692401" @default.
• W2048692401 workType "article" @default.